Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE IN VITRO AND IN VIVO METABOLISM OF Δ6a,10a DIMETHYL HEPTYL TETRAHYDROCANNABINOL (DMHP)

Louis Lemberger, Robert E. McMahon, Robert A. Archer, Ken Matsumoto and Howard Rowe
Journal of Pharmacology and Experimental Therapeutics October 1973, 187 (1) 169-175;
Louis Lemberger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert E. McMahon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Archer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Matsumoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard Rowe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

14C-Δ6a, 10a dimethyl heptyl tetrahydrocannabinol (DMHP) is metabolized to three more polar metabolites by the 9000 x g liver supernatant of several animal species. Under our in vitro conditions, rabbits and mice metabolize DMHP to a greater extent than rats, guinea pigs and dogs, the latter possessing the least activity. DMHP metabolism by rabbit liver is markedly diminished by incubation in nitrogen and in the presence of boiled enzyme. After the intravenous administration of DMHP to rats and rabbits, the rate of disappearance of the parent compound and its metabolites from plasma is biphasic. The T½ of the secondary slow phase is about 24 hours in both species. One to three hours after DMHP administration the highest concentration of radioactivity is present in liver, lung and spleen. The concentration in the brain is low compared to other tissues. In the rat 70% of the administered dose of radioactivity was recovered after 14C-DMHP administration (4% in urine and 66% in feces). In the rabbit 87% of 14C was recovered (24% in urine and 63% in feces). The metabolites in feces appeared to be neutral compounds, whereas the major portion of the urinary metabolites was acidic in nature. In rabbits the plasma half-life and pattern of excretion of DMHP are different from that reported to occur with Δ9-tetrahydrocannabinol. The results suggest that in the rabbit the prolonged plasma T½ seen after DMHP administration may be related in part to a different excretory pathway for DMHP as opposed to that found after Δ9-tetrahydrocannabinol administration to this species.

Footnotes

    • Received September 28, 1972.
    • Accepted June 4, 1973.
  • © 1973 by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 187, Issue 1
1 Oct 1973
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE IN VITRO AND IN VIVO METABOLISM OF Δ6a,10a DIMETHYL HEPTYL TETRAHYDROCANNABINOL (DMHP)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE IN VITRO AND IN VIVO METABOLISM OF Δ6a,10a DIMETHYL HEPTYL TETRAHYDROCANNABINOL (DMHP)

Louis Lemberger, Robert E. McMahon, Robert A. Archer, Ken Matsumoto and Howard Rowe
Journal of Pharmacology and Experimental Therapeutics October 1, 1973, 187 (1) 169-175;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE IN VITRO AND IN VIVO METABOLISM OF Δ6a,10a DIMETHYL HEPTYL TETRAHYDROCANNABINOL (DMHP)

Louis Lemberger, Robert E. McMahon, Robert A. Archer, Ken Matsumoto and Howard Rowe
Journal of Pharmacology and Experimental Therapeutics October 1, 1973, 187 (1) 169-175;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Reduction of 5-Hydroxytryptamine (5-HT)1A-Mediated Temperature and Neuroendocrine Responses and 5-HT1A Binding Sites in 5-HT Transporter Knockout Mice
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics